Kymera Therapeutics, Inc. financial data

Symbol
KYMR on Nasdaq
Location
500 North Beacon Street, 4 Th Floor, Watertown, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 4, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 793 % +5.36%
Debt-to-equity 16.7 % -28%
Return On Equity -33.4 % -33.6%
Return On Assets -28.6 % -41%
Operating Margin -760 % -232%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 71.9M shares +11.1%
Common Stock, Shares, Outstanding 71.7M shares +10.8%
Entity Public Float 1.15B USD +13.2%
Common Stock, Value, Issued 7K USD 0%
Weighted Average Number of Shares Outstanding, Basic 87.3M shares +14.7%
Weighted Average Number of Shares Outstanding, Diluted 87.3M shares +14.7%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 43.7M USD -50.1%
Cost of Revenue 43.7M USD -26.1%
Research and Development Expense 305M USD +37.6%
General and Administrative Expense 67.6M USD +10%
Operating Income (Loss) -332M USD -66%
Income Tax Expense (Benefit) 200K USD
Net Income (Loss) Attributable to Parent -295M USD -76.2%
Earnings Per Share, Basic -3 USD/shares -53.8%
Earnings Per Share, Diluted -3 USD/shares -53.8%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 113M USD +2.02%
Accounts Receivable, after Allowance for Credit Loss, Current 40M USD
Assets, Current 528M USD -7.11%
Property, Plant and Equipment, Net 45.1M USD -11.9%
Operating Lease, Right-of-Use Asset 42.9M USD -10.6%
Other Assets, Noncurrent 6.83M USD
Assets 1.1B USD +6.49%
Accounts Payable, Current 5.51M USD -15.2%
Accrued Liabilities, Current 28.6M USD +7.95%
Contract with Customer, Liability, Current 23.3M USD +16.3%
Liabilities, Current 71.6M USD +7.58%
Contract with Customer, Liability, Noncurrent 14M USD
Operating Lease, Liability, Noncurrent 68.5M USD -7.04%
Other Liabilities, Noncurrent 0 USD
Liabilities 156M USD +9.78%
Accumulated Other Comprehensive Income (Loss), Net of Tax 1.5M USD -22.3%
Retained Earnings (Accumulated Deficit) -979M USD -43.2%
Stockholders' Equity Attributable to Parent 946M USD +5.97%
Liabilities and Equity 1.1B USD +6.49%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -79.2M USD -99.9%
Net Cash Provided by (Used in) Financing Activities 258K USD -99.9%
Net Cash Provided by (Used in) Investing Activities 48.6M USD
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 71.7M shares +10.8%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -30.3M USD -84.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 77K USD +57.1%
Deferred Tax Assets, Valuation Allowance 236M USD +45.5%
Deferred Tax Assets, Gross 260M USD +41.1%
Operating Lease, Liability 80.3M USD -5.69%
Depreciation 7.4M USD +17.5%
Payments to Acquire Property, Plant, and Equipment 467K USD -93.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -296M USD -81.2%
Lessee, Operating Lease, Liability, to be Paid 116M USD -9.37%
Property, Plant and Equipment, Gross 67.5M USD +3.3%
Operating Lease, Liability, Current 11.9M USD +3%
Lessee, Operating Lease, Liability, to be Paid, Year Two 12.8M USD +3%
Lessee, Operating Lease, Liability, to be Paid, Year One 12.4M USD +3%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 35.6M USD -16.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 13.2M USD +3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 13.6M USD +3%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 2.05M USD +40.2%
Deferred Tax Assets, Net of Valuation Allowance 23.6M USD +8.54%
Share-based Payment Arrangement, Expense 59.3M USD +13.7%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares